Now showing items 1-3 of 3

    Issue DateTitleAuthor(s)
    28 January 2012Characterization of TAE684 as a potent LRRK2 kinase inhibitor  Zhang, J; Deng, X; Choi, HG; et al.
    7 July 2012GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent- N-arylbenzamide LRRK2 kinase inhibitor  Reith, AD; Bamborough, P; Jandu, K; et al.
    7 January 2020Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a  Zhang, J; Bhuiyan, MIH; Zhang, T; et al.